# Ranolazine

NDC: 0904-7506
Generic name: Ranolazine
Labeler / Manufacturer: Major Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20250117

FDA application: ANDA209953

## Active ingredients

- RANOLAZINE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0904-7506"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0904-7506
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6166c40c-4fbe-47c4-92e4-2dc5d3567a86